126 related articles for article (PubMed ID: 15151697)
1. Long term physiologic modification using rAAV in utero gene-therapy.
Garrett DJ; Cohen JC; Larson JE
Genet Vaccines Ther; 2004 May; 2(1):4. PubMed ID: 15151697
[TBL] [Abstract][Full Text] [Related]
2. In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates.
Garrett DJ; Larson JE; Dunn D; Marrero L; Cohen JC
BMC Biotechnol; 2003 Sep; 3():16. PubMed ID: 14519209
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
[TBL] [Abstract][Full Text] [Related]
4. Post-injury delivery of rAAV2-CNTF combined with short-term pharmacotherapy is neuroprotective and promotes extensive axonal regeneration after optic nerve trauma.
Hellström M; Pollett MA; Harvey AR
J Neurotrauma; 2011 Dec; 28(12):2475-83. PubMed ID: 21861632
[TBL] [Abstract][Full Text] [Related]
5. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
6. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
[TBL] [Abstract][Full Text] [Related]
7. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
8. CD151 promotes neovascularization and improves blood perfusion in a rat hind-limb ischemia model.
Lan RF; Liu ZX; Liu XC; Song YE; Wang DW
J Endovasc Ther; 2005 Aug; 12(4):469-78. PubMed ID: 16048379
[TBL] [Abstract][Full Text] [Related]
9. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
Braun-Falco M; Doenecke A; Smola H; Hallek M
Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
[TBL] [Abstract][Full Text] [Related]
10. [Study on time effect of gene expression of recombinant adeno-associated virus vector co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes].
Zhang C; Qiang H; Dang X; Wang K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep; 24(9):1121-7. PubMed ID: 20939488
[TBL] [Abstract][Full Text] [Related]
11. Glucose-modulated transgene expression via recombinant adeno-associated virus.
Yang YW; Hsieh YC; Chao CK
Pharm Res; 2002 Jul; 19(7):968-75. PubMed ID: 12180549
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus-mediated vascular endothelial growth factor gene therapy in skeletal muscle before transplantation promotes revascularization of regenerating muscle.
Smythe GM; Lai MC; Grounds MD; Rakoczy PE
Tissue Eng; 2002 Oct; 8(5):879-91. PubMed ID: 12459067
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.
Turner RT; Dube M; Branscum AJ; Wong CP; Olson DA; Zhong X; Kweh MF; Larkin IV; Wronski TJ; Rosen CJ; Kalra SP; Iwaniec UT
J Endocrinol; 2015 Dec; 227(3):129-41. PubMed ID: 26487675
[TBL] [Abstract][Full Text] [Related]
14. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.
Lipshutz GS; Gruber CA; Cao Y ; Hardy J; Contag CH; Gaensler KM
Mol Ther; 2001 Mar; 3(3):284-92. PubMed ID: 11273769
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats.
Storek B; Harder NM; Banck MS; Wang C; McCarty DM; Janssen WG; Morrison JH; Walsh CE; Beutler AS
Mol Pain; 2006 Jan; 2():4. PubMed ID: 16445862
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
18. The DNA minor groove binding agents Hoechst 33258 and 33342 enhance recombinant adeno-associated virus (rAAV) transgene expression.
Li L; Yang L; Kotin RM
J Gene Med; 2005 Apr; 7(4):420-31. PubMed ID: 15538728
[TBL] [Abstract][Full Text] [Related]
19. Remote delivery of rAAV-GFP to the rat brainstem through the recurrent laryngeal nerve.
Rubin AD; Hogikyan ND; Sullivan K; Boulis N; Feldman EL
Laryngoscope; 2001 Nov; 111(11 Pt 1):2041-5. PubMed ID: 11801993
[TBL] [Abstract][Full Text] [Related]
20. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.
Reimsnider S; Manfredsson FP; Muzyczka N; Mandel RJ
Mol Ther; 2007 Aug; 15(8):1504-11. PubMed ID: 17565350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
